Mark Klempner
Inventions:
Title: Broadly Borreliacidal Human Monoclonal Antibodies to OspA and their Uses. UMMS15-03; Patent Pending.
-
The invention provides anti-OspA antibodies and methods of use as a pre-exposure prophylactic against all three pathogenic Borrelia species causing Lyme disease.
- Inventors: Biologics
- Applications: Infectious Disease, Borrelia, Borreliacidal/lyme, Human monoclonal, Antibody
- Inventors: Biologics
Innovation Topics: Biologics, Infectious Disease, Borrelia, Borreliacidal/lyme, Human monoclonal, Antibody